Summary

How GLGSQ maps according to Revere

Sector Level Count
Industries 1
Sectors 1
Subsectors 1
Product/Service Groups 1

Specific product example for GLGSQ

Product Hierarchy
Healthcare
Biopharmaceuticals
Oncology
Phase I/Phase II Clinical Stage Products

Company Highlights:

Market Cap. 0.141
Current Shares Outstnd. 14.1
Contact Name
Contact Phone (617)4220674
City, State Boston, MA
Dividends Per Common Share 0.00
Dividend Yield n/a
SI %SHOUT 0.65
IH % Shares Outst. 0.49%
Number of Employees 16
Revenue Per Employee n/a
Book Value Per Share 0.04
5 Year CAGR in Revenues % n/a
5 Year CAGR in Earnings % n/a
Asset Turnover 0
Fiscal Year End 12/31/2005
Next Reporting Period Dec, 2005

Business Description:

GlycoGenesys, Inc. is a biotechnology company focused on carbohydrate-based drug development. The Company's lead drug candidate is GCS-100. The Company has also developed agricultural products, some of which are also based upon carbohydrate chemistries. During the year ended December 31, 2004, GlycoGenesys has two wholly owned non-operating subsidiaries: International Gene Group, Inc. and SafeScience Products, Inc. GlycoGenesys has two wholly owned subsidiaries, International Gene Group, Inc. (IGG) and SafeScience Products, Inc. (SafeScience Products). These subsidiaries are non-operating subsidiaries.

Chart:

Last Price 0.01
Price Chg. 0.00
Price Chg. % 0.00%
Open Price 0.01
High Price 0.01
Low Price 0.01
52w High Price 0.03
52w Low Price 0.01
Volume 2,500
30d Avg. Volume 7,743
GLGSQ - Chart
* Quotes delayed 20 minutes.

Competitors by Products

Products Manufactured/Services Performed/Product Name(s) - Competitors (Tickers)/Product Name(s):
Healthcare
Biopharmaceuticals
Oncology
Phase I/Phase II Clinical Stage Products

Products:

  • GCS-100
  • GCS-100LE

Abbott Laboratories (ABT) Products:

  • ABT 751 (Tubulin Inhibitor)
  • ABT-263 (Bcl-2 Antagonist)
  • ABT-510 (Thrombospondin-1 Mimicking Agent)
  • ABT-869 (VEGFR Kinase Inhibitor)

Access Pharmaceuticals, Inc. (ACCP) Products:

  • ProLindac (DACH Polymer Platinate)
  • Somanta Sodium Phenylbutyrate/VP101

Acusphere, Inc. (ACUS) Products:

  • AI-850 (Hydrophobic Drug Delivery System (HDDS) Paclitaxel)

Adherex Technologies Inc. (USA) (ADH) Products:

  • ADH-1 (N-Cadherin Antagonist)
  • Eniluracil
  • STS (Sodium Thiosulfate)

ADVENTRX Pharmaceuticals, Inc. (ANX) Products:

  • CoFactor (ANX-510)

AEterna Zentaris Inc. (USA) (AEZS) Products:

  • AEZS-108/Formerly Zentaris AN-152 (Targeted Cytotoxic Peptide Conjugates)
  • AEZS-112/Formerly ZEN-012
  • Perifosine (Alkylphosphocholine Compound )
  • Zentaris Ozarelix/D-63153 (LHRH Antagonist)
  • Zentaris RC-3095 (Bombesin Receptor Antagonist)

Alfacell Corporation (ACEL) Products:

  • ONCONASE (Ranpirnase)

Allos Therapeutics, Inc. (ALTH) Products:

  • PDX (Pralatrexate)
  • PDX (Pralatrexate)/Gemcitabine Combination
  • RH1 (DT-Diaphosporase Activated Chemotherapeutic)

Ambrilia Biopharma Inc. (AMB:CA) Products:

  • PCK3145

AMDL, Inc. (ADL) Products:

  • Combination Immunogene Therapy (CIT)

Amgen, Inc. (AMGN) Products:

  • AMG 102
  • AMG 386
  • AMG 479
  • AMG 655
  • AMG 706 (Motesanib Diphosphate)
  • Apo2L/TRAIL (PRO1762)
  • Denosumab
  • Vectibix (Panitumumab)

Anadys Pharmaceuticals, Inc. (ANDS) Products:

  • ANA773 (Toll-Like Receptor-7 (TLR-7) Agonist)

Antigenics, Inc. (AGEN) Products:

  • Aroplatin (Platinum)
  • ATRA-IV (All-Trans Retinoic Acid (ATRA))
  • HSPPC-70/AG-858 (Vaccine)
  • Oncophage (Vitespen)

Aphton Corporation (APHTQ) Products:

  • IGN101 (Cancer Vaccine)
  • IGN311 (Humanized Monoclonal Antibody)

APP Pharmaceuticals, Inc. (APPX) Products:

  • ABI-008 (NAB-Docetaxel)
  • ABI-010 (Heat Shock Protein Inhibitor)
  • Abraxane (Paclitaxel Protein-Bound Particles For Injectable Suspension)

Ardea Biosciences, Inc. (RDEA) Products:

  • RDEA119 (Mitogen-Activated ERK Kinase (MEK) Inhibitor)

Ariad Pharmaceuticals, Inc. (ARIA) Products:

  • MK-8669/AP23573 (Deforolimus)

ArQule, Inc. (ARQL) Products:

  • ARQ 171 (E2F1 Pathway Activator)
  • ARQ 197 (c-Met inhibitor)
  • ARQ 501 (E2F1 Pathway Activator)

Array BioPharma Inc. (ARRY) Products:

  • ARRY-380 (ErbB-2 Inhibitor)
  • ARRY-520 (Kinesin Spindle Protein Inhibitor)
  • ARRY-543 (EGFR/ErbB-2 Inhibitors)
  • ARRY-704/AZD8330 (MEK Inhibitor)
  • ARRY-797 (p38 Inhibitor)
  • ARRY-886/AZD6244 (MEK Inhibitor)
  • ICOS IC83 (CHK-1 Inhibitor)

Arrowhead Research Corporation (ARWR) Products:

  • Insert Therapeutics IT-101 (Cyclosert Camptothecin)

AstraZeneca plc (ADR) (AZN) Products:

  • Abraxane (Paclitaxel Protein-Bound Particles For Injectable Suspension)
  • ARRY-886/AZD6244 (MEK Inhibitor)
  • AZD0530 (SRC Kinase Inhibitor)
  • AZD1152 (Aurora Kinase Inhibitor)
  • AZD1689 (Hypoxia Activated Cytotoxic)
  • AZD2281 (Poly-ADP Ribose Polymerase (PARP) Inhibitor)
  • AZD4769
  • AZD4877
  • AZD5438 (Selective Cyclin Dependent Kinase Inhibitor)
  • AZD5896 (AGT Inhibitor)
  • AZD7762
  • AZD8330
  • AZD8931
  • CAT-3888 (Recombinant Immunotoxin)
  • Iressa (Gefitinib)
  • MedImmune Ethyol (Amifostine)
  • MedImmune MT103/MEDI-538 (Recombinant T-Cell Engaging Anti-CD19 Antibody)
  • MedImmune Retaspimycin/Formerly IPI-504 (Hsp90 inhibitor)
  • MedImmune Siplizumab (Monoclonal Antibody - Formerly MEDI-507)
  • MT201 (Adecatumumab)
  • Zactima (Vandetanib)
  • ZD4054 (Endothelin Receptor Antagonist)

Avalon Pharmaceuticals, Inc. (AVRX) Products:

  • AVN944 (Inosine 5' Monophosphate Dehydrogenase Inhibitor)

AVANT Immunotherapeutics, Inc. (AVAND) Products:

  • CDX-110 (EGFR Variant III)
  • CDX-1307-01
  • CDX-1307-02

AVAX Technologies, Inc. (AVXT) Products:

  • L-Vax (Autologous Cell Vaccine)

AVI BioPharma, Inc. (AVII) Products:

  • Oncomyc-NG AVI-4126 (Antisense Drug)

Baxter International Inc. (BAX) Products:

  • Leupromaxx (Sustained-Released Peptide Hormone Leuprolide Acetate)

Bayer AG (ADR) (BAYRY) Products:

  • BAY 59-8862 (IDN 5109)
  • Berlex MS-275 (Histone Deacytelators)
  • Berlex MS209 (Multidrug Resistance Modulator)
  • Berlex PTK787 (Vatalanib)
  • Nexavar (Sorafenib)
  • Novel Taxane
  • Schering Oral Multi-target Tumor Growth Inhibitor (MTGI)
  • Schering ZK-EPO (Epothilone)

BioCryst Pharmaceuticals, Inc. (BCRX) Products:

  • Fodosine (Forodesine)

Biogen Idec Inc. (BIIB) Products:

  • CNF2024 (HSP Inhibitor)
  • Volociximab (M200)

Bioniche Life Sciences (BNC:CA) Products:

  • Urocidin (Mycobacterial Cell Wall DNA Complex)

Bionovo Inc. (BNVI) Products:

  • BZL101 (Apoptosis Inducer)

BioSpecifics Technologies Corp. (BSTC) Products:

  • Xiaflex (Injectable Collagenase)/Formerly AA4500

Bradmer Pharmaceuticals Inc. (BMR:CA) Products:

  • Neuradiab (Radiolabeled Conjugated Monoclonal Antibody)

Bristol Myers Squibb Co. (BMY) Products:

  • BMS-582664 (Brivanib Alaninate)
  • BMS-641988
  • BMS-690514
  • Elsamitrucin
  • Erbitux (Cetuximab)
  • Ixempra (Ixabepilone)
  • MDX-010/BMS-734016 (Ipilimumab)
  • Sprycel (Dasatinib)

Callisto Pharmaceuticals, Inc. (KAL) Products:

  • Atiprimod
  • L-Annamycin

CEL-SCI Corporation (CVM) Products:

  • Multikine (Leukocyte Interleukin)

Celgene Corporation (CELG) Products:

  • CC-4047 (Immunomodulatory Drug)
  • CC-8490 (Benzopyran)
  • Focalin (Refined D-Methylphenidate HCl)
  • Pharmion MGCD0103 (Histone Deacetylase (HDAC) Inhibitor)
  • Pharmion Oral Azacitidine
  • Pharmion Vidaza (Azacitidine)
  • Revlimid (Lenalidomide)

Cell Genesys, Inc. (CEGE) Products:

  • CG0070 Oncolytic Virus Therapy
  • GVAX Leukemia
  • GVAX Pancreatic Cancer
  • GVAX Prostate Cancer

Cell Therapeutics, Inc. (CTIC) Products:

  • Brostallicin (DNA Minor Groove Binding Agent)
  • CT-2106 (Polyglutamate-Camptothecin)
  • Pixantrone (BBR 2778)
  • XYOTAX (Paclitaxel Poliglumex)
  • Zevalin (Ibritumomab Tiuxetan)

Celsion Corporation (CLN) Products:

  • Thermodox (Doxorubicin)

Cephalon, Inc. (CEPH) Products:

  • CEP-701(Lestaurtinib)
  • Trisenox (Arsenic Trioxide)

Cerus Corporation (CERS) Products:

  • CRS-100 (Attenuated Listeria Cancer Vaccine)

ChemGenex Pharmaceuticals Limited (ADR) (CXSP) Products:

  • Omacetaxine Mepesuccinate/Formerly Ceflatonin
  • Quinamed (Amonafide Dihydrochloride)

Chemokine Therapeutics Corp. (CTI:CA) Products:

  • CTCE-9908 (Stromal Cell-derived Factor Antagonist)

Cleveland BioLabs, Inc. (CBLI) Products:

  • Curaxins CBLC102 (Apoptosis Modulator)

CombinatoRx, Incorporated (CRXX) Products:

  • CRx-026 (Chlorpromazine/Pentamidine)

Cougar Biotechnology, Inc. (CGRB) Products:

  • CB3304 (Noscapine)
  • CB7630 (Abiraterone Acetate)

CuraGen Corporation (CRGN) Products:

  • CR011-vcMMAE (Anti-Proliferation Compound)
  • Intravenous PXD101 (Belinostat)
  • Oral PXD101 (Belinostat)

Curis, Inc. (CRIS) Products:

  • GDC-0449 (Hedgehog Systemic Small Molecule Antagonist)

Cyclacel Pharmaceuticals Inc. (CYCC) Products:

  • CYC116 (Aurora Kinase Inhibitors)
  • Sapacitabine/CYC682 (Nucleoside Analog)
  • Seliciclib (Cyclin Dependent Kinase (CDK) Inhibitor)

Cytogen Corporation (CYTO) Products:

  • CYT-500
  • Quadramet (Samarium Sm-153 Lexidronam)

Cytokinetics, Inc. (CYTK) Products:

  • GSK-923295 (Centromere Associated Protein E (CENP-E) Inhibitor)
  • Ispinesib/SB-715992 (Kinesin Spindle Protein Inhibitor)
  • SB-743921 (Kinesin Spindle Protein Inhibitor)

DARA BioSciences, Inc. (DARA) Products:

  • PT-100 (Talabostat)

Delcath Systems, Inc. (DCTH) Products:

  • Delcath System With Melphalan

Dendreon Corporation (DNDN) Products:

  • Neuvenge (Lapuleucel-T)
  • Provenge (Sipuleucel-T)
  • rNAPc2 (Recombinant Nematode Anticoagulant Protein c2)

Dr. Reddy's Laboratories Limited (ADR) (RDY) Products:

  • DRF-1042

DUSA Pharmaceuticals, Inc. (DUSA) Products:

  • Levulan PDT (Aminolevulinic Acid)

Dynavax Technologies Corporation (DVAX) Products:

  • TLR-9 Agonist
  • TOLAMBA (Immunostimulatory Sequences)

Eisai Co., Ltd (ADR) (ESALY) Products:

  • E7070 (Sulfonamide)
  • E7080 (VEGF Inhibitor)
  • E7389 (Antimicrotubule Agent)
  • E7820
  • E7974 (Antimicrotubule Agent)
  • MGi Pharma Dacogen (Decitabine)
  • MGi Pharma Irofulven (Hydroxymethylacylfulvene)
  • MGi Pharma ZYC300 (DNA Based Immunostimulant)
  • Ontak (Denileukin Diftitox)
  • Panretin Capsules (Alitretinoin)
  • Targretin Capsules (Bexarotene)

Eli Lilly & Co. (LLY) Products:

  • Alimta (Pemetrexed)
  • Anti-CD20 Antibody
  • Arzoxifene
  • ASAP
  • Enzastaurin
  • Gemzar (Gemcitabine)
  • ICOS IC83 (Cell Cycle Checkpoint/DNA Repair Antagonist)
  • LY2181308 (Antisense Survivin Inhibitor)
  • LY2275796 (eIF-4E Antisense Therapeutic)
  • LY293111
  • TGF Beta Inhibitors Program

Endo Pharmaceuticals (ENDP) Products:

  • Rapinyl (Sublingual Fentanyl)

EntreMed, Inc. (ENMD) Products:

  • ENMD-1198 (Modified 2-Methoxyestradiol)
  • MKC-1 (Cell Cycle Inhibitor)
  • Panzem (2-Methoxyestradiol (2ME2))
  • Panzem NCD (2-Methoxyestradiol (2ME2))

Enzon Pharmaceuticals, Inc. (ENZN) Products:

  • Oncaspar (Pegaspargase)
  • PEG-SN38/EZN-2208 (Active Metabolite Of Irinotecan)
  • rhMBL (Recombinant Human Mannose-Binding Lectin)
  • SPC/ENZ2968 (HIF-1 Alpha Antagonist)

EpiCept Corporation (EPCT) Products:

  • Azixa/MPC-6827 (Tubulin Inhibitor)
  • EP90745

Exelixis, Inc. (EXEL) Products:

  • XL019 (Selective JAK2 Inhibitor)
  • XL147 (Phosphoinositide-3 Kinase (PI3K) Inhibitor)
  • XL184 (VEGFR/Met Inhibitor)
  • XL228 (Insulin-Like Growth Factor Receptor Inhibitor)
  • XL281 (RAF Kinase Inhibitor)
  • XL418 (PKB/S6K Inhibitor)
  • XL518 (MEK Inhibitor)
  • XL647 (Tyrosine Kinase Receptor Inhibitor)
  • XL820 (VEGFR2/PDGFR/KIT Inhibitor)
  • XL844 (CHK1/2 Kinase Inhibitor)
  • XL880 (VEGFR/Met Inhibitor)
  • XL999 (GFR Inhibitor)

Favrille, Inc. (FVRL) Products:

  • FAV-201 (Patient-Specific Immunotherapy)
  • Specifid (Mitumprotimut-T)/Formerly FavId

Flamel Technologies S.A. (ADR) (FLML) Products:

  • Medusa Interleukin-2 XL

Genaera Corporation (GENR) Products:

  • Squalamine Lactate

Genentech, Inc. (DNA) Products:

  • ABT-263 (Bcl-2 Antagonist)
  • ABT-869 (VEGFR Kinase Inhibitor)
  • Apo2L/TRAIL (PRO1762)
  • Apomab (Proapoptotic Receptor Agonist)
  • Avastin (Bevacizumab)
  • Avastin (Bevacizumab)/Sutent (Sunitinib)
  • GDC-0449 (Hedgehog Systemic Small Molecule Antagonist)
  • Herceptin (Trastuzumab)/Omnitarg (Pertuzumab)
  • IAP Antagonist (Inhibitors Of Apoptosis)
  • INO 101 PARP Inhibitor (Poly ADP-Ribose Polymerase Inhibitors)
  • MetMAb
  • Ocrelizumab/R1594 (Humanized Anti-CD20 Monoclonal Antibody)
  • Omnitarg (Pertuzumab)
  • SGN-40 (Anti-CD40 Antibody)2
  • Tanox TNX-650 (Humanized Anti-IL13 Antibody)
  • Trastuzumab-DM1
  • XL518 (MEK Inhibitor)

Generex Biotechnology Corporation (GNBT) Products:

  • Antigen Express AE37

Genitope Corporation (GTOP) Products:

  • MyVax Personalized Immunotherapy

Genta Incorporated (GNTA) Products:

  • G4460 (C-Myb Antisense)
  • Ganite (Gallium Nitrate)
  • Genasense (Oblimersen Sodium)
  • Tesetaxel/Formerly DJ-927 (Oral Taxane)

Gentium S.p.A. (ADR) (GENT) Products:

  • Defibrotide

GenVec, Inc. (GNVC) Products:

  • TNFerade (TNF alpha Gene/Radiation Responsive Promoter)

Genzyme Corporation (GENZ) Products:

  • Atiprimod
  • Bioenvision Modrenal (Trilostane)
  • Genzyme Oncology Clolar (Clofarabine)
  • Genzyme Oncology Tasidotin
  • Hectorol Capsules (Doxercalciferol)
  • Intravenous Picoplatin (Platinum-Based Compound)
  • Thymoglobulin (Anti-Thymocyte Globulin)

Geron Corporation (GERN) Products:

  • GRN163L (Lipidated Telomerase Inhibitor)
  • GRNVAC1 (Telomerase Cancer Vaccine)

Gilead Sciences, Inc. (GILD) Products:

  • GS 9219 (Nucleotide Analog)

GlaxoSmithKline plc (ADR) (GSK) Products:

  • Cervarix (HPV16/HPV18 Vaccine)
  • Iboctadekin/Rituximab Combination Therapy
  • Ispinesib/SB-715992
  • MAGE-A3 ASCI (Cancer Vaccine)
  • Pazopanib
  • SB-743921 (Kinesin Spindle Protein Inhibitor)
  • Tykerb (Lapatinib Ditosylate)
  • XL880 (VEGFR/Met Inhibitor)

GPC Biotech AG (ADR) (GPCB) Products:

  • 1D09C3 (Anti-MHC Monoclonal Antibody)
  • Orplatna (Satraplatin)

Halozyme Therapeutics, Inc. (HALO) Products:

  • Chemophase

Hana Biosciences, Inc. (HNAB) Products:

  • Alocrest (Vinorelbine Tartrate Liposomes Injection)
  • Marqibo (Sphingosomal Vincristine)
  • Talvesta (Talotrexin)

Hemispherx BioPharma, Inc (HEB) Products:

  • Ampligen (Double Stranded RNA Toll-Like Receptor-3 Agonist)

Human Genome Sciences (HGSI) Products:

  • HGS-ETR1 (Mapatumumab)
  • HGS-ETR2 (Lexatumumab)

Idera Pharmaceuticals, Inc. (IDRA) Products:

  • IMO-2055 (TLR9 Agonist)

IDM Pharma Inc. (IDMI) Products:

  • Bexidem (Monocyte-derived Activated Killer (MAK) Cells)
  • Collidem (Specific Antigen Peptide)
  • IDM-2101 (Tumor-Specific Cytotoxic T Lymphocyte Epitopes)
  • Uvidem (Tumor Cell Lysate)

ImClone Systems Incorporated (IMCL) Products:

  • Erbitux (Cetuximab)
  • IMC-1121B (IMC/KDR Antibodies)
  • IMC-11F8 (EGFR Inhibitor Monoclonal Antibody)
  • IMC-18F1 (VEGFR-1 Monoclonal Antibody)
  • IMC-3G3 (Platelet-Derived Growth Factor Receptor Alpha Monoclonal Antibody Inhibitor (PDGFR-Alpha))
  • IMC-A12 (VEGFR-2/IGF-1R Modulator)

ImmunoGen, Inc. (IMGN) Products:

  • AVE1642 (Anti-IGF-1 R Antibody)
  • AVE9633 (huMy9-6 Monoclonal Antibody)
  • IMGN242/Formerly huC242-DM4
  • IMGN901/Formerly huN901-DM1
  • SAR3419
  • Trastuzumab-DM1

Immunomedics, Inc. (IMMU) Products:

  • IBC Pharmaceuticals Bi-Specific Fused Antibodies
  • IMMU-100/Unlabeled CEA Antibody (Labetuzumab)
  • IMMU-101/Y-90 CEA Antibody (Labetuzumab Y-90)
  • IMMU-102/Epratuzumab Y-90 (Y-90-Labeled Anti-CD22 Antibody)
  • IMMU-103/Epratuzumab (Anti-Cd22 Antibody)
  • IMMU-107 (PAM4 Antibody Y-90)
  • IMMU-111/CEA Antibody (Labetuzumab-I-131)
  • Milatuzumab (CD74-Antibody)
  • Veltuzumab/IMMU-106 (Anti-CD20 Monoclonal Antibody)

Incyte Corporation (INCY) Products:

  • INCB18424 (Janus-Associated Kinase (JAK) Inhibitor)
  • INCB7839 (Sheddase Inhibitor)

Infinity Pharmaceuticals Inc. (INFI) Products:

  • Retaspimycin/Formerly IPI-504 (Hsp90 inhibitor)

Inovio Biomedical Corp. (INO) Products:

  • Electroporation DNA Delivery Therapy
  • Electroporation Drug Therapy
  • Electroporation Technology Interleukin-2 (IL-2)
  • Electroporation Therapy With Bleomycin

Insmed Incorporated (INSM) Products:

  • INSM-18 (Tyrosine Kinase Inhibitor)
  • Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGFBP-3)

Introgen Therapeutics, Inc (INGN) Products:

  • ADVEXIN (Formerly INGN 201)
  • INGN 225 (p53 Immunotherapy Vaccine)
  • INGN 234 (p53 Tumor Suppressor (Advexin) Oral Rinse Formulation)
  • INGN 241 (mda-7 Gene Therapy)
  • INGN 401 (Nanoparticle Formulation FUS-1)

ISIS Pharmaceuticals, Inc. (ISIS) Products:

  • LY2181308 (Antisense Survivin Inhibitor)
  • LY2275796 (eIF-4E Antisense Therapeutic)
  • OGX-011 (Antisense Clusterin Inhibitor)
  • OGX-427 (Antisense Protein Inhibitor)

Johnson & Johnson (JNJ) Products:

  • Andarine
  • Centocor CNTO 95
  • GeneVax CEA
  • R115777 (Farnesyl Transferase Inhibitor)
  • SPI-077 (Cisplatin/Liposome)

Keryx Biopharmaceuticals (KERX) Products:

  • KRX-0401 (Perifosine)
  • KRX-0402 (O6-Benzyl Guanine)
  • KRX-0601 (7-hydroxytaurosporine)

Kosan Biosciences Incorporated (KOSN) Products:

  • KOS-1022 (Alvespimycin HCl)
  • KOS-1584 (Epothilone)
  • KOS-953 (Tanespimycin)

Large Scale Biology Corp. (LSBC) Products:

  • Non-Hodgkin's Lymphoma (NHL) Vaccine

Lorus Therapeutics Inc. (USA) (LRP) Products:

  • GTI-2501 (Antisense Agent)
  • LOR-2040 (Antisense Agent)

MannKind Corporation (MNKD) Products:

  • MKC1106-PP Immunotherapy

Marshall Edwards, Inc. (MSHL) Products:

  • NV-196 (Triphendiol)
  • Oral Phenoxodiol
  • Phenoxodiol (Pan Kinase Inhibitor)

MDS Inc. (USA) (MDZ) Products:

  • Hemosol HRC-302 (T-Cell Therapy)

Medarex, Inc. (MEDX) Products:

  • CNTO 95
  • CP-675,206 (Ticilimumab)
  • FG-3019 (Anti-CTGF Antibody)
  • HGS-TR2J
  • HuMax-CD4 (Zanolimumab)
  • IMC-18F1 (VEGFR-1 Modulator)
  • IMC-3G3 (Platelet-Derived Growth Factor Receptor Alpha Inhibitor (PDGFR-Alpha))
  • MDX-010 (Ipilimumab)
  • MDX-060 (Anti-CD30 Antibody)
  • MDX-1106/ONO-4538 (anti-PD-1 Antibody)
  • MDX-1307
  • MDX-1342 (Anti-CD19 Antibody)
  • MDX-1401 (Anti-CD30 Antibody)
  • MDX-1411 (Anti-CD70 Antibody)
  • MDX-214 (Anti-EGFr/CD89 Antibody)

MediciNova, Inc. (MNOV) Products:

  • MN-029 (Vascular Disrupting Agent (VDA))

Medivation, Inc. (MDVN) Products:

  • MDV3100

Merck & Co., Inc. (MRK) Products:

  • MK-0429
  • MK-0457/VX-680 (Aurora Kinase Inhibitor)
  • MK-0646
  • MK-0731
  • MK-0752
  • MK-4721
  • MK-8669 (Deforolimus)
  • Odanacatib/Formerly MK-0822
  • V502 HPV Vaccine
  • V930 Cancer Vaccine

Merck KGaA Products:

  • Merck Serono Adecatumumab (Monoclonal Antibody)
  • Merck Serono Atacicept/TACI-Ig
  • Merck Serono HuMax-CD4 (Zanolimumab)
  • Merck Serono R763 (Aurora Kinase Inhibitor)

Metabasis Therapeutics, Inc. (MBRX) Products:

  • MB07133 (Cytarabine Prodrug)

MethylGene Inc. (MYG:CA) Products:

  • MGCD0103 (Histone Deacetylase (HDAC) Inhibitor)

Micromet Inc. (MITI) Products:

  • BiTE MT103/MEDI-538 (Recombinant T-Cell Engaging Anti-CD19 Antibody)
  • MT201(Adecatumumab)
  • MT293/TRC093 (Recombinant Humanized IgG1 Monoclonal Antibody)

Millennium Pharmaceuticals, Inc. (MLNM) Products:

  • MLN518 (Flt-3 Receptor Tyrosine Kinase Inhibitor)
  • MLN8054 (Aurora A Kinase Inhibitor)
  • MLN8237 (Aurora A Kinase Inhibitor)
  • Velcade (Bortezomib)

Molecular Insight Pharmaceuticals, Inc. (MIPI) Products:

  • Azedra (I-131Metaiodobenzylguanidine)
  • Onalta (Edotreotide)

Myriad Genetics, Inc. (MYGN) Products:

  • Azixa/Formely MPC-6827 (Tubulin Inhibitor)
  • MPC-2130 (Apoptosis Inducer)

Nektar Therapeutics (NKTR) Products:

  • CDP 791 (PEG-antibody Fragment Angiogenesis Inhibitor)
  • NKTR-102 (PEG-Irinotecan)

NeoPharm, Inc. (NEOL) Products:

  • IL13-PE38QQR (Cintredekin Besudotox)
  • Liposome Encapsulated c-raf Antisense Oligonucleotide (LE-rafAON)
  • Liposome Encapsulated Paclitaxel-Easy To Use (LEP-ETU)
  • Liposome Encapsulated SN38 (LE-SN38)

Neoprobe Corporation (NEOP) Products:

  • Lymphoseek

Novacea, Inc. (NOVC) Products:

  • AQ4N (Banoxantrone)
  • Asentar/DN-101 (Oral Calcitriol)

Novartis AG (ADR) (NVS) Products:

  • ABF656 (Albuferon-alpha)
  • ABJ879 (Microtubule Stabilizer)
  • AEE788 (Tyrosine Kinase Inhibitor)
  • Chiron CHIR-12.12 (Anti-CD40)
  • Chiron CHIR-258
  • Chiron CHIR-265
  • Chiron Proleukin (Aldesleukin)
  • EPO906 (Epothilone B)
  • Gleevec (Imatinib Mesylate)
  • LAQ824
  • LBH589 (Histone Deacetylase (HDAC) Inhibitor)
  • LBQ707 (Gimatecan)
  • Patupilone (Microtubule Stabilizer)
  • PKC412 (Midostaurin)
  • RAD001 (Everolimus)
  • SOM230 (Pasireotide)

Novo Nordisk A/S (ADR) (NVO) Products:

  • Anti-KIR (IgG4 Monoclonal Antibody)
  • Interleukin 21 (IL-21)

Novogen Limited (ADR) (NVGN) Products:

  • Marshall Edwards Oral Phenoxodiol
  • Marshall Edwards Phenoxodiol (Pan Kinase Inhibitor)
  • Marshall Edwards Triphendiol/Formerly NV-196

Nuvelo, Inc. (NUVO) Products:

  • rNAPc2 (Recombinant Nematode Anticoagulant Protein c2)

Nuvo Research Inc. (NRI:CA) Products:

  • WF10

Oncolytics Biotech, Inc. (USA) (ONCY) Products:

  • REOLYSIN (Reovirus Formulation)

Oncothyreon Inc. (ONTY) Products:

  • PX-12 (Thioredoxin Inhibitor)
  • PX-478 (HIF-1a Inhibitor)

Onyx Pharmaceuticals, Inc. (ONXX) Products:

  • Nexavar (Sorafenib)

Optimer Pharmaceuticals, Inc. (OPTR) Products:

  • OPT-822/OPT-821 Combination Therapy (Carbohydrate-based Immunostimulant)

OSI Pharmaceuticals, Inc. (OSIP) Products:

  • Avastin (Bevacizumab)/Tarceva (Erlotinib HCl)
  • CP-868,596 (Platelet-Derived Growth Factor Receptor Inhibitor)
  • Novantrone (Mitoxantrone Hydrochloride)
  • OSI-906 (Insulin-Like Growth Factor-1 Receptor Inhibitor)
  • OSI-930 (c-kit/VEGFR-2 Inhibitor)
  • OSI632/Formerly CP 547,632 (VEGFR Inhibitor)
  • Tarceva (Erlotinib)

OXiGENE, Inc. (OXGN) Products:

  • Oxi4503 (Next Generation Vascular Targeting Agent)
  • Zybrestat (Combretastatin A-4 Prodrug Combination Therapy)

Pain Therapeutics, Inc. (PTIE) Products:

  • Radio-Labeled Monoclonal Antibody Program

Par Pharmaceutical Companies, Inc. (PRX) Products:

  • Strativa ONCONASE (Ranpirnase)

PDL BioPharma Inc. (PDLI) Products:

  • HuLuc63 (Monoclonal Antibody)
  • M200 (Volociximab)

Peregrine Pharmaceuticals (PPHM) Products:

  • Bavituximab/Formerly Tarvacin (Anti-PhosphatidylSerine Monoclonal Antibody)
  • Cotara (Iodine 131 Monoclonal Antibody)

Pfizer Inc. (PFE) Products:

  • AG-24322
  • Axitinib
  • CE-245677
  • Coley Pharmaceutica VaxImmune
  • CP-675,206 (Ticilimumab)
  • CP-751871
  • CP-868,596 (Platelet-Derived Growth Factor Receptor Inhibitor)
  • CP-870893 (CD40-Agonist Monoclonal Antibody)
  • PD 332991 (Cell Cycle Kinases)
  • PD-325901
  • PF-2341066
  • PF-299804
  • PF-337210
  • PF-3512676 (Promune)
  • PF-3814735
  • PF-562271
  • SU-14813
  • Sutent (Sunitinib Malate)

Pharmacopeia, Inc. (PCOP) Products:

  • PS095760

Pharmacyclics, Inc. (PCYC) Products:

  • PCI-24781 (Histone Deacetylase (HDAC) Inhibitor)
  • Xcytrin (Motexafin Gadolinium)

Poniard Pharmaceuticals, Inc. (PARD) Products:

  • Intravenous Picoplatin (Platinum-Based Compound)
  • Oral Picoplatin

Pro-Pharmaceuticals, Inc. (PRW) Products:

  • DAVANAT-1

Progen Pharmaceuticals Limited (USA) (PGLA) Products:

  • CGC 11047 (Polyamine Analog)
  • PI-166
  • PI-88 (Angiogenesis/Heparanase Inhibitor)

Progenics Pharmaceuticals, Inc. (PGNX) Products:

  • PSMA Development Company PSMA Recombinant Protein Vaccine

ProMetic Life Sciences Inc. (PLI:CA) Products:

  • ProMetic BioSciences PBI-1393

Protherics PLC (ADR) (PTIL) Products:

  • Acadra (Acadesine)
  • OncoGel (Intratumoural Injectable Paclitaxel)
  • Prolarix

Regeneron Pharmaceuticals, Inc. (REGN) Products:

  • Aflibercept (VEGF Trap)

Rigel Pharmaceuticals, Inc. (RIGL) Products:

  • R763/AS703569 (Aurora Kinase Inhibitor)
  • R788 (Oral Syk Kinase Inhibitor)

Roche Holding Ltd. (ADR) (RHHBY) Products:

  • AHM (Anti-HM 1.24 Monoclonal Antibody)
  • AS1404
  • Avastin (Bevacizumab)
  • CAL (Anti-PTHrP Monoclonal Antibody)
  • CHC 12103 (Polyglutamate TXL)
  • Diflomotecan (Topoisomerase Inhibitor I)
  • E2F Activating Compound
  • Omnitarg (Pertuzumab)
  • Pemtumomab/R1549
  • PRO64553 (Anti-CD40 Antibody)
  • R1273 (Monoclonal Antibody)
  • R1492 (Enzyme Inhibitor)
  • R1536 (Enzyme Inhibitor)
  • R1550 (Monoclonal Antibody)
  • R1564/DMXAA (Vascular Targeting Agent)
  • R1594/ Ocrelizumab (Humanized Anti-CD20 Monoclonal Antibody)
  • R1668 (E2F Modulator)
  • Tarceva (Erlotinib)
  • Therafab
  • Therex
  • Trastuzumab-DM1

Sanofi-Aventis SA (ADR) (SNY) Products:

  • Aflibercept (VEGF Trap)
  • AVE1642 (Anti-IGF)
  • AVE8062 (Combretastatin Derivative)
  • AVE9633 (Monoclonal Antibody)
  • SAR3419 (Tubulin Inhibitor)
  • SSR 244738 (Antitumoral Agent)
  • XRP6258 (Taxoid, Tubulin Inhibitor)

Schering-Plough Corporation (SGP) Products:

  • Sarasar (Lonafarnib)
  • Temodar (Temozolomide)

SciClone Pharmaceuticals, Inc. (SCLN) Products:

  • RP101 (Nucleoside Analog)
  • Zadaxin (Thymalfasin)

Seattle Genetics, Inc. (SGEN) Products:

  • SGN-15 (Anti CD-40 Antibody)
  • SGN-30 (Anti-CD30 Monoclonal Antibody)
  • SGN-33 ( Lintuzumab (Anti-CD30 Monoclonal Antibody))
  • SGN-35 (Anti-CD30 Monoclonal Antibody)
  • SGN-40 (Anti-CD40 Antibody)

SGX Pharmaceuticals, Inc. (SGXP) Products:

  • SGX523 (MET Tyrosine Kinase Inhibitor)

Sonus Pharmaceuticals, Inc. (SNUS) Products:

  • SN2310 (TOCOSOL Camptothecin)

Spectrum Pharmaceuticals, Inc. (SPPI) Products:

  • Elsamitrucin
  • Lucanthone
  • Orplatna (Satraplatin)
  • Ortataxel (Third Generation Taxane)
  • Ozarelix (SPI-153)
  • SPI-1620 (Endothelin B Agonist)

Sunesis Pharmaceuticals, Inc. (SNSS) Products:

  • SNS-032 (Cyclin-Dependent Kinase Inhibitor)
  • SNS-314 (Aurora Kinase Inhibitor)
  • SNS-595 (Naphthyridine Analogue)

SuperGen, Inc. (SUPG) Products:

  • Avicine (Synthetic Cancer Vaccine)
  • CZ 112 (Rubitecan Pro-Drug)
  • Dacogen (Decitabine)
  • MP470 (Multi-targeted Tyrosine Kinase Inhibitor)

Synta Pharmaceuticals Corp. (SNTA) Products:

  • STA-9090 (Heat Shock Protein 90 (Hsp90) Inhibitor)

Tapestry Pharmaceuticals, Inc. (TPPH) Products:

  • TPI 287 (Taxanes)

Tekmira Pharmaceuticals Corporation (TKM:CA) Products:

  • Alocrest (Vinorelbine Tartrate Liposomes Injection)/INX-0125
  • Brakiva/Formerly INX-0076 (Sphingosomal Encapsulated Topotecan)
  • Marqibo (Sphingosomal Vincristine)

Telik, Inc. (TELK) Products:

  • Telcyta (TLK286)

Tercica, Inc. (TRCA) Products:

  • Dopastatin

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Products:

  • IVAX Cervene
  • IVAX Talampanel (AMPA Inhibitor)
  • IVAX Xorane (Oral Paclitaxel)
  • StemEx (Cord Blood Stem/Progenitor Cells)

Thallion Pharmaceuticals Inc. (TLN:CA) Products:

  • CAP-232 (M2 Pyruvate Kinase (M2PK) Inhibitor)
  • ECO-4601 (RAS-MAPK Inhibitor)

Threshold Pharmaceuticals, Inc. (THLD) Products:

  • 2-Deoxyglucose (2DG)
  • Glufosfamide
  • TH-302 (Angiogenesis Inhibitors)

Titan Pharmaceuticals, Inc. (TTP) Products:

  • Gallium Maltolate

Trubion Pharmaceuticals, Inc. (TRBN) Products:

  • TRU-015 (Small Modular Immunopharmaceutical (SMIP))
  • TRU-016 (Small Modular Immunopharmaceutical (SMIP))

Vernalis plc (ADR) (VNLSY) Products:

  • Hsp90 Inhibitors

Vertex Pharmaceuticals Incorporated (VRTX) Products:

  • AVN-944/VX-944 (Inosine 5' Monophosphate Dehydrogenase Inhibitor (IMPDH Inhibitor))
  • MK-0457/VX-680 (Aurora Kinase Inhibitor)

Vical Incorporated (VICL) Products:

  • Interleukin-2 w/ Electroporation Technology (IL-2/EP)
  • Therapeutic DNA Vaccine

Vion Pharmaceuticals, Inc. (VION) Products:

  • Cloretazine/VNP40101M (Sulfonyl Hydrazine Prodrug)
  • Intravenous Triapine
  • Oral Triapine

Viragen, Inc. (VRAI) Products:

  • Multiferon (Human Leukocyte Derived Interferon)

ViRexx Medical Corp. (USA) (REX) Products:

  • BrevaRex
  • Occlusin 50 Injection
  • OvaRex (Oregovomab)

Wyeth (WYE) Products:

  • CMC-544 (Inotuzumab)
  • HKI-272
  • MST-997
  • SKI-606 (Bosutinib)
  • TTI-237

XOMA Limited (XOMA) Products:

  • HCD122 (Anti-CD40 Antibody)
  • ING-1 (Anti-Ep-CAM Antibody)

YM BioSciences Inc. (USA) (YMI) Products:

  • Nimotuzumab/Formerly TheraCIM HR3 (EGFR Monoclonal Antibody)
  • RadioTheraCIM (Monoclonal Antibody/EGFR Inhibitor)
  • Tesmilifene

ZIOPHARM Oncology Inc. (ZIOP) Products:

  • Intravenous ZIO-101 (Darinaparsin)
  • Intravenous ZIO-201 (Palifosfamide (Isophosphoramide Mustard))
  • Oral ZIO-101 (Darinaparsin)
  • Oral ZIO-301 (Indibulin)

ZymoGenetics, Inc. (ZGEN) Products:

  • Atacicept/Formerly TACI-Ig
  • Interleukin 21 (IL-21)

Key Financials

FY Ends September
Period Length/End 3 months
ending
09/30/2005 		3 months
ending
06/30/2005 		3 months
ending
09/30/2004 		12 months
ending
12/31/2004 		12 months
ending
12/31/2003 		12 months
ending
12/31/2002
Total Revenue 0.0 0.0 0.0 0.0 0.0 0.0
Gross Margin % n/a n/a n/a n/a n/a n/a
Operating Income -2.2 -2.1 -2.7 -10.2 -7.7 -5.8
Operating Margin % n/a n/a n/a n/a n/a n/a
Tax Rate % 0 0 0 0 0 0
Income After Taxes -2.2 -2.1 -2.7 -10.1 -7.6 -10.1
Net Income Margin % n/a n/a n/a n/a n/a n/a
F.D. EPS - Incl. Xord. Items -0.18 -0.22 -0.28 -1.15 -1.18 -2.07
Book Value Per Share 0.04 0.23 0.35 0.13 0.34 0.97

Ratios

P/R Ratio (TTM) n/a
P/E Ratio (TTM) 0.00
Price To Free Cash Flow (TTM) -0.02
Price To Book Value 0.28
Net Assets to Market Cap. % 2,134.46%
Beta 2.29
Days to Sell Inventory n/a
Current Ratio 1.03
Quick Ratio 0.81
Interest Coverage n/a
Debt to Market Cap. % 0.00%
Return on Equity % -1,694.88
Return on Assets % -297.04
Return on Invested Capital % -1,698.1

Business/Geographical Segments